Regulatory Compliance and Quality Assurance Support

This contract seeks QA/QC support services specifically tailored to Valsartan manufacturing operations, with a focus on ensuring regulatory compliance and operational integrity. Key responsibilities include the thorough review of batch records, management of deviations, implementation of corrective and preventive actions (CAPA), and maintaining readiness for FDA audits. The work requires expertise in pharmaceutical quality systems and a deep understanding of current good manufacturing practices to uphold product quality and regulatory standards throughout the manufacturing lifecycle. The scope demands precision, documentation rigor, and proactive risk mitigation aligned with FDA expectations. The contract is classified as a subcontract under NAICS code 541611 and is issued by the Department of Defense through DLA Troop Support. It was posted on June 23, 2026, with a response deadline of July 23, 2026, at 7:00 PM. Although no specific location for performance is listed, services are expected to support manufacturing activities related to Valsartan, likely within a regulated pharmaceutical facility. The effort requires a qualified provider capable of operating in a highly compliant environment with minimal oversight, delivering results that directly impact product safety, regulatory standing, and supply chain reliability.